Capital Flow Monitor · Sponsors · CIK 1811209
Kriya Therapeutics, Inc.
4105 HOPSON ROAD, MORRISVILLE, NC, 27560 · (833) 574-9289
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$320.8M
Sold
$320.8M
% sold
100.0%
Investors
10
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-10 | D/A ·current | 506(b) | $320.8M | $320.8M | 100.0% | 10 | EDGAR ↗ |
| 2025-08-15 | D | 506(b) | $313.3M | $313.3M | 100.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- James Momtazee — Director, Morrisville, NC
- Ilan Oren — Director, Morrisville, NC
- Shankar Ramaswamy — Executive Officer / Director, Morrisville, NC
- Trit Garg — Director, Morrisville, NC
- Ryan Gallagher — Director, Morrisville, NC
- Roger Jeffs — Director, Morrisville, NC
- Keith Manchester — Director, Morrisville, NC
- Akshay Rai — Director, Morrisville, NC
- Saira Ramasastry — Director, Morrisville, NC
- Neelaksh Varshney — Director, Morrisville, NC
- Curt Herberts — Executive Officer, Morrisville, NC
- Katherine Eade — Executive Officer, Morrisville, NC
- Brian Furmanski — Executive Officer, Morrisville, NC
- Britt Petty — Executive Officer, Morrisville, NC
- Michele Stone — Executive Officer, Morrisville, NC
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.